Henry Schein, Inc. (HSIC)
| Market Cap | 9.26B |
| Revenue (ttm) | 10.12B |
| Net Income (ttm) | 403.79M |
| Shares Out | 142.50M |
| EPS (ttm) | 2.82 |
| PE Ratio | 23.08 |
| Forward PE | 17.09 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | February 24 |
| Last Price | $65.01 |
| Previous Close | $65.62 |
| Change ($) | -0.61 |
| Change (%) | -0.93% |
| Day's Open | 65.18 |
| Day's Range | 64.90 - 66.66 |
| Day's Volume | 1,174,599 |
| 52-Week Range | 41.85 - 74.89 |
We think that Henry Schein currently is a better pick compared to Boston Scientific. HSIC stock trades at about 0.9x trailing Revenues, compared to around 5.5x for Boston Scientific.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. has been recognized by Ethisphere as one of the 2021 World's Most Ethical Companies.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. announced that it will virtually present at the 2021 Barclays Global Healthcare Conference on March 9, 2021.
Henry Schein Opens Customer Assistance Hotline in Response to Winter Storms Across the United States
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers in the Southern, Mid-Atlantic, and Northeastern states that the Henry Schein Customer Assistance Hotlin...
The dental equipment market seems ready to grow as it continues to recover from the COVID-19 pandemic slump, making it prudent to look at names like Henry Schein (HSIC) and McKesson (MCK)
Henry Schein (HSIC) sees robust segmental performance in Q4 boosted by strong rebound in sales, and solid demand for PPE and COVID-19-related products.
Henry Schein CEO on how to make the U.S. vaccine rollout more efficient
Medical supply distributor Henry Schein has a unique view on the pandemic and the recovery. Henry Schein CEO Stanley Bergman joined "Squawk Box" on Wednesday to give his insight on the vaccine...
Henry Schein (HSIC) delivered earnings and revenue surprises of 4.17% and 10.70%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Henry Schein (NASDAQ:HSIC) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share were up 3.09% year over year to $1.00, which beat the estimate o...
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. reports fourth quarter 2020 financial results from continuing operations.
Henry Schein (HSIC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Henry Schein's (HSIC) medical business' PPE sales are likely to have maintained its momentum along with global recovery trends of the dental business during Q4.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. announced that Mohamad Ali and Deborah Derby have been appointed as members of the Company's Board of Directors.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. to webcast fourth quarter and full-year 2020 conference call on Wednesday, February 17, 2021.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. has been named to the FORTUNE® “World's Most Admired Companies” list for 2021, the 20th consecutive year it has been so honored.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein Earns Top Marks In Human Rights Campaign's 2021 Corporate Equality Index
Here are some dirt-cheap MedTech value stocks which are expected to provide long-term gains in 2021.
The developments are expected to strengthen Henry Schein's (HSIC) presence in high potential and still-untapped markets.
Henry Schein Acquires Majority Interest in Prism Medical Products, Enters Home Medical Supply Market
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. acquires majority interest in Prism Medical Products and enters the home medical supply market.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. completes joint venture with Casa Schmidt to offer an expanded array of products and services to customers in Spain and Portugal.
As the Covid-19 pandemic worsens, the case for dental stocks to buy might not seem too bright. However, this sector is a very broad one, with upside opportunities available right now.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. will virtually present at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021, at 7:30 a.m. Eastern time.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein Medical, the U.S. Medical business of Henry Schein, Inc., today announced the availability of Ansell Healthcare Product's AlphaTec® Model 214 gown...
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein Medical, the U.S. medical business of Henry Schein, Inc., recently entered into a distribution agreement with Yosi Health, a provider of digital p...
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. will open the Nasdaq Stock Market in commemoration of its 25th anniversary as a publicly traded company.
Is Henry Schein (HSIC) a great pick from the value investor's perspective right now? Read on to know more.
More households own pets than have children, and they'll pay to keep their furry friends happy. Here are 6 big pet stocks.
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein Announces Virtual Presence at Greater New York Focused on 3D Imaging, 3D Printing, and CAD/CAM Solutions
Henry Schein has had a period of sequential growth, fuelled entirely by Covid-related demand and PPE distribution. Covid exposure is an interesting factor for the company, presenting near-term...
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. announced that the Company will present at several virtual investor conferences in December.
CALGARY, Alberta--(BUSINESS WIRE)-- #albertadentist--With businesses everywhere struggling to keep their doors open, one small firm has big reasons to celebrate. Stream Dental Staffing Solutio...
Henry Schein, Inc.'s (HSIC) CEO Stanley Bergman on Q3 2020 Results - Earnings Call Transcript
Henry Schein, Inc. (HSIC) CEO Stanley Bergman on Q3 2020 Results - Earnings Call Transcript
Henry Schein (HSIC) sees robust segmental performance in Q3 boosted by strong rebound in sales and solid demand for PPE and COVID-19-related products.
Henry Schein (HSIC) delivered earnings and revenue surprises of 43.06% and 16.55%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. reported record third quarter 2020 financial results from continuing operations.
Several medical product stocks have come up with bullish earnings reports so far this reporting cycle. Let's see how STE, HSIC, PACB, INSP are poised ahead of their announcements.
Henry Schein (HSIC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
3 Dental Supplies Stocks Set to Shine on the Industry's Upturn
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. today announced its exclusive distribution agreement with Carrizo Dental, a leading Córdoba-based distributor of dental supplies and equipme...
Henry Schein's (HSIC) medical business' PPE sales are likely to have maintained its momentum along with global recovery trends of the dental business during Q3.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein announces participation in upcoming virtual conferences in November.
Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MELVILLE, N.Y.--(BUSINESS WIRE)--TDSC.com, Powered by Henry Schein is live and will continue to offer members with an everyday low-price, online option for obtaining dental supplies.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. will release its third quarter 2020 financial results before the stock market opens on Monday, November 2, 2020.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) announced today that it has been named to FORTUNE® magazine’s "Change the World" list, an annual ranking of companies that ha...
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc.
Henry Schien's (HSIC) customer base is likely to benefit from the Teledent platform.
About HSIC
Henry Schein, a solutions company for health care professionals, provides health care products and services to office-based dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates in two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth,... [Read more...]
| Industry Medical Distribution | IPO Date Nov 3, 1995 |
| CEO Stanley Bergman | Employees 19,000 |
| Stock Exchange NASDAQ | Ticker Symbol HSIC |
Financial Performance
In 2020, Henry Schein's revenue was $10.12 billion, an increase of 1.34% compared to the previous year's $9.99 billion. Earnings were $403.79 million, a decrease of -41.88%.
Analyst Forecasts
According to 17 analysts, the average rating for Henry Schein stock is "Buy." The 12-month stock price forecast is 74.67, which is an increase of 14.86% from the latest price.